|Day's Range||8.07 - 8.21|
|52 Week Range||3.21 - 8.21|
|PE Ratio (TTM)||-7.52|
|Earnings Date||Mar 7, 2017 - Mar 13, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||9.50|
Looking at growth outlooks and price targets, these four small-cap stocks could have a stellar rest of 2017.
Looking at growth outlooks and price targets, these four small-cap stocks could have a stellar 2017.
Spectrum Pharmaceuticals, Inc. , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced the presentation of data from a clinical study of FOLOTYN plus Romidepsin in patients with relapsed or refractory Peripheral T-Cell Lymphoma in an oral presentation session which was presented at the 14th International Conference ...